scispace - formally typeset
P

Philip C. Calder

Researcher at University of Southampton

Publications -  808
Citations -  70822

Philip C. Calder is an academic researcher from University of Southampton. The author has contributed to research in topics: Polyunsaturated fatty acid & Eicosapentaenoic acid. The author has an hindex of 125, co-authored 747 publications receiving 59110 citations. Previous affiliations of Philip C. Calder include Southampton General Hospital & Radboud University Nijmegen Medical Centre.

Papers
More filters
Journal ArticleDOI

Uptake and incorporation of saturated and unsaturated fatty acids into macrophage lipids and their effect upon macrophage adhesion and phagocytosis.

TL;DR: The results suggest that membrane fluidity is important in determining macrophage adhesion and phagocytic activity, and may be possible to modulate the activity of cells of the immune system, and so an immune response, by dietary lipid manipulation.
Journal ArticleDOI

Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans

TL;DR: Divergent effects of cis-9,trans-11 CLA and trans-10,cis-12 CLA appear on the blood lipid profile in healthy humans: trans-8,9,9 CLA increases LDL:HDL cholesterol and total: HDL cholesterol, whereas cis-7,8,8 CLA decreases them.
Journal ArticleDOI

Markers to measure immunomodulation in human nutrition intervention studies

TL;DR: It would be valuable to include several immune markers in addition to clinical outcome in future clinical trials in this area, as there is too little evidence that correlates markers with global health improvement.
Journal ArticleDOI

Nutrition, immunity and COVID-19.

TL;DR: It would seem prudent for individuals to consume sufficient amounts of essential nutrients to support their immune system to help them deal with pathogens should they become infected.
Journal ArticleDOI

Metabolism and functional effects of plant-derived omega-3 fatty acids in humans

TL;DR: If conversion of ALA to EPA and DHA is limited, then ALA may have a smaller health benefit than EPA andDHA, and SDA appears to offer better potential for health improvement than ALA.